Upgrade to SI Premium - Free Trial

argenx (ARGX)

983.02 +3.26 (0.33%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (10/22/26)

Latest Headlines

argenx SE (ARGX:BB) (ARGX) PT Raised to EUR1,100 at Barclays September 8, 2026 5:37 AM - StreetInsider argenx SE (ARGX) PT Raised to $1,250 at Morgan Stanley August 31, 2026 8:09 AM - StreetInsider argenx SE (ARGX:BB) (ARGX) PT Raised to EUR1,010 at Kepler Cheuvreux August 28, 2026 3:56 AM - StreetInsider Form 6-K ARGENX SE For: Aug 27 August 27, 2026 4:20 PM - SEC Filing argenx SE (ARGX) PT Raised to $1,415 at Wells Fargo August 26, 2026 6:24 AM - StreetInsider UBS Upgrades argenx SE (ARGX) to Buy August 26, 2026 3:24 AM - StreetInsider Deutsche Bank Downgrades argenx SE (ARGX:BB) (ARGX) to Hold August 24, 2026 10:13 AM - StreetInsider argenx SE (ARGX) PT Raised to $1,230 at Morgan Stanley August 18, 2026 8:54 AM - StreetInsider argenx SE (ARGX) PT Raised to $1,100 at Oppenheimer August 18, 2026 7:44 AM - StreetInsider argenx SE (ARGX) PT Raised to $1,100 at RBC Capital, 'We Think Approval In DM Is When, Not If' August 18, 2026 7:33 AM - StreetInsider argenx SE (ARGX) PT Raised to $1,202 at H.C. Wainwright August 18, 2026 6:50 AM - StreetInsider argenx SE (ARGX:BB) (ARGX) PT Raised to EUR1,000 at Barclays August 18, 2026 5:05 AM - StreetInsider argenx SE (ARGX) PT Raised to $1,200 at Citizens on VYVGART Indication Expansion August 18, 2026 4:09 AM - StreetInsider Citi keeps this biotech stock a top pick after trial clears key efficacy milestone August 18, 2026 3:00 AM - StreetInsider argenx SE (ARGX) PT Raised to $1,095 at Truist Securities August 17, 2026 4:08 PM - StreetInsider argenx SE (ARGX) PT Raised to $1,115 at Leerink August 17, 2026 2:25 PM - StreetInsider argenx SE (ARGX) PT Raised to $1,353 at TD Cowen August 17, 2026 2:24 PM - StreetInsider argenx SE (ARGX) PT Raised to $1,150 at Wedbush August 17, 2026 10:29 AM - StreetInsider Form 6-K ARGENX SE For: Aug 17 August 17, 2026 8:54 AM - SEC Filing argenx SE (ARGX) PT Raised to $1,215 at Piper Sandler August 17, 2026 7:43 AM - StreetInsider Zai Lab and argenx report Phase 3 trial win for myositis drug August 17, 2026 6:00 AM - StreetInsider Zai Lab and argenx Announce Positive Topline Results from Phase 3 ALKIVIA Trial of Efgartigimod in Autoimmune Myositis August 17, 2026 6:00 AM - BizWire Form SCHEDULE 13G/A ARGENX SE Filed by: PRICE T ROWE ASSOCIATES INC /MD/ August 14, 2026 10:39 AM - SEC Filing argenx launches $77-per-share tender offer for Forte Biosciences August 6, 2026 7:49 AM - StreetInsider argenx Announces Commencement of Tender Offer to Acquire Forte Biosciences, Inc. August 6, 2026 7:48 AM - Globe NewsWire Guggenheim Resumes argenx SE (ARGX) at Buy August 4, 2026 1:04 PM - StreetInsider Form 6-K ARGENX SE For: Aug 03 August 3, 2026 4:13 PM - SEC Filing argenx SE (ARGX:BB) (ARGX) PT Raised to EUR980 at Barclays July 29, 2026 5:08 AM - StreetInsider H.C. Wainwright Reiterates Buy Rating on argenx SE (ARGX) July 28, 2026 6:42 AM - StreetInsider argenx SE (ARGX) PT Raised to $1,050 at Wedbush July 27, 2026 10:38 AM - StreetInsider TD Cowen Downgrades Forte Biosciences Inc. (FBRX) to Hold July 27, 2026 8:14 AM - StreetInsider argenx SE (ARGX) PT Raised to $932 at Baird July 27, 2026 7:04 AM - StreetInsider Form 6-K ARGENX SE For: Jul 27 July 27, 2026 6:03 AM - SEC Filing argenx SE (ARGX) PT Raised to $1,200 at Morgan Stanley July 24, 2026 9:38 AM - StreetInsider argenx SE (ARGX) PT Raised to $1,037 at Oppenheimer July 24, 2026 8:15 AM - StreetInsider H.C. Wainwright Reiterates Buy Rating on argenx SE (ARGX) July 24, 2026 7:25 AM - StreetInsider argenx SE (ARGX) PT Raised to $1,185 at Guggenheim July 24, 2026 6:59 AM - StreetInsider argenx SE (ARGX) PT Raised to $1,025 at RBC Capital July 24, 2026 6:50 AM - StreetInsider argenx SE (ARGX) PT Raised to $1,350 at Wells Fargo July 24, 2026 6:29 AM - StreetInsider argenx SE (ARGX:BB) (ARGX) PT Raised to EUR950 at Barclays July 24, 2026 4:45 AM - StreetInsider argenx SE (ARGX) PT Lowered to $932 at Citizens After Q2 Beat July 24, 2026 4:01 AM - StreetInsider argenx SE (ARGX) PT Raised to $1,282 at Stifel July 23, 2026 10:26 AM - StreetInsider Form 6-K ARGENX SE For: Jun 30 July 23, 2026 8:22 AM - SEC Filing argenx (ARGX) Tops Q2 EPS by 97c July 23, 2026 3:24 AM - StreetInsider argenx SE (ARGX) PT Raised to $1,182 at Citi July 21, 2026 5:09 AM - StreetInsider argenx to Report Half Year 2026 Financial Results and Second Quarter Business Update on July 23, 2026 July 16, 2026 1:00 AM - Globe NewsWire argenx SE (ARGX) PT Raised to $945 at RBC Capital July 7, 2026 7:59 AM - StreetInsider argenx SE (ARGX:BB) (ARGX) PT Raised to EUR900 at Deutsche Bank July 3, 2026 3:03 AM - StreetInsider argenx SE (ARGX) PT Raised to $1,088 at BofA Securities July 1, 2026 4:35 PM - StreetInsider Wells Fargo Lists 8 Tactical Ideas for Q3 2026 July 1, 2026 6:22 AM - StreetInsider H.C. Wainwright Reiterates Buy Rating on argenx SE (ARGX) June 25, 2026 6:48 AM - StreetInsider Buy this biotech stock on weakness: Barclays June 25, 2026 3:00 AM - StreetInsider TD Cowen Reiterates Buy Rating on argenx SE (ARGX) June 24, 2026 9:45 AM - StreetInsider RBC Capital on argenx SE (ARGX): 'We Are Buyers On Myositis Stock Weakness' June 24, 2026 9:37 AM - StreetInsider argenx SE (ARGX) PT Raised to $1,180 at Morgan Stanley June 24, 2026 8:24 AM - StreetInsider Oppenheimer Reiterates Outperform Rating on argenx SE (ARGX) June 24, 2026 6:30 AM - StreetInsider argenx SE (ARGX) Reiterated at Market Outperform by Citizens: Ph3 Results on Track for Q3 June 24, 2026 4:12 AM - StreetInsider Form 6-K ARGENX SE For: Jun 23 June 23, 2026 6:23 AM - SEC Filing argenx to Host Autoimmune Myositis R&D Webinar June 23, 2026 1:00 AM - Globe NewsWire UBS Reiterates Neutral Rating on argenx SE (ARGX:BB) (ARGX) June 22, 2026 8:22 AM - StreetInsider Full Article List